Geron Corp. Shares Display Perfect Head-and-Shoulders Pattern
What a site, Geron Corp. (NASDAQ:GERN) shares are displaying a beautiful head-and-shoulders pattern. From $5 a share in May to $9 in July then back down to $5 level today. Stem Cells were all the rage a few months ago, now they've just lost steam.
Geron is the company that made news with its stem cell therapy showing benefits in treating spine injuries in rodents' cervical region.
Geron's experimental therapy, GRNOPC1 had earlier run into safety problems as rodents being treated for spinal cord injury in the thoracic region developed a kind of tumor in the animal studies, which prompted the U.S. health regulator to put an early-stage trial on hold.
Data from the current animal study could be used to release the clinical hold and testing the therapy in patients with spinal injuries in the cervical region, the Food and Drug Administration had said in October.
Last month, the stem cell research company said GRNOPC1, reduced tissue damage and improved recovery of nerve function in the proof-of-concept study.
Seven days after injury, rodents treated with GRNOPC1 did not have a cavity in the spinal cord, had more preserved nerve units, and more neurons with their protective covering myelin, Geron said.
Back to the head-and-shoulders pattern, here's a larger view of the chart thanks to finviz.com. So could the stock be a bottom? You make the call.
Disclaimer: No positions in GERN.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Prince Bandar bin Sultan, Head Of Saudi Intelligence, Has Been Sacked | ZeroHedge
- Guest Post: The Slow Death Of The Old Global Order | ZeroHedge
- Facebook Takes Life Seriously and Moves To Create Its Own Virtual Currency, Increases UltraCoin Valuation Significantly | ZeroHedge
- Risk On, Regardless | Financial Sense
- The Futures Of Countries: A Look At The Secession Movements Around The World | ZeroHedge
- How Will Gold Respond to Global Deflation? | Financial Sense
- Baltic Dry Drops For 15th Day To Lowest In 9 Months (Back Below $1000) | ZeroHedge
The most relevant financial news and articles from the Internets
- Guy Buys Scale On Amazon, And Now Amazon Thinks He's A Drug Dealer | Business Insider
- Three Charts Show How Healthcare Costs Have Exploded Since 1960 | Business Insider
- Here Are Your Chances Of Winning $100,000 From The St. Louis Rams For Picking A Perfect NFL... | Business Insider
- CONFIRMED: Dutch Police Make Arrest In Teen Twitter Terror Threat | Business Insider
- Bitcoin Is On A Bit Of A Tear | Business Insider
- Bezos Dials in Amazon Smartphone, Citi's 'Stress'-ed Earnings | TheStreet.com
- Tablets Lead Play Requests For 'TV... | Business Insider